(Date:5/16/2008)...USTON - Gefitinib, the once-promising drug formerl...cer, also known as Iressa, enhanced the effectiven...fic types of metastatic breast cancer, according t...The University of Texas M. D. Anderson Cancer Cent...t the first positive study for Iressa in breast ca...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- Behavioral ...ponding to the needs of the millions,of Americans ...ce use,conditions each year, according to the late...Psychiatric Health Systems (NAPHS) released today....nct views of behavioral,healthcare delivery. One c...
(Date:5/16/2008)...y announces appointment of Nomura Code Securities ... sole broker, NEW YORK, May 16 /PRNewswire-FirstC...l Investments, Inc. (Amex: MGT ) (the "Company"),...uter-Aided Detection (CAD) and,image analysis soft...nosis,of disease, today announced the appointment ...
(Date:5/16/2008)...T, Conn., May 16 /PRNewswire/ -- Tao Formulations ...opause Relief Formula, at the Internal,Medicine 20... product is,the culmination of years of research t...gen-free) alternative for relieving menopausal sym... board certified obstetrician,and gynecologist, fo...
Breaking Medicine News(10 mins):Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 2Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 3Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Tao Formulations Announces the Official Launch of Tao Harmony - Menopause Relief Formula 2...marital arguments can have devasting consequences ...cing age //. The National Institute on Aging has c...tal Quality and Health Over the Life Course' which...s can contribute to stress. The stress can infact...
...-Gooden, a clinical psychologist and author, a lot...emotional overeater’s who try to mask their depres...rican women generally do not seek treatment for th...igious community and family members don't recogniz...
...ent that lifted up faces and brought cheer to the ...the tabs for three types of obesity surgery, in c...blems. // But the catch is that, only surgeries p...rgeons or the American Society of Bariatric Surger...
...vices Group Inc. has announced that it will be mak...h prostate cancer//. This move comes, as the survi...etter chemotherapy as well as early diagnosis and ...plans at standard rates "to men 60 and older who h...
Other Medicine News:Health News:Marriage Squabbles Can Make You Sick 2Health News:African-American Women Need To Seek Advice On depression 2(Date:5/16/2008)...TAN, N.J., May 16 /- Veridex, LLC ann...ratory Corporation of America Holdings,(LabCorp), ...est for,prostate cancer. The new assay uses the bi...ate cancer, detecting the methylation of the gene,...occurs primarily in,cancer. Veridex is developing ...
(Date:5/15/2008)... Results Confirm Efficacy for Population Most Affe...lif., May 16 /-,Bayer Healt...ls, Inc.,(Nasdaq: ONXX ) today announced that Nex... overall survival by 47.3 percent (HR=0.68;,p-valu...th advanced,hepatocellular carcinoma (HCC), or pri...
(Date:5/15/2008)...FRANCISCO, May 15 /- Mediva...ata from an ongoing Phase 1-2 clinical,trial of it...l be presented,in an oral presentation at the 44th...al Meeting in Chicago., Session title: New Targ... Session date and time: Monday, June 2 at 11:30 a....
(Date:5/15/2008)...II Data Presented at ASCO Showed Acceptable Tolera...Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N.J., M...rapeutic agent eribulin mesylate (E7389) demonstra... women with locally advanced or metastatic,breast ...se II clinical,trial. The study also suggests that...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3First wind turbines on Galapagos Islands will halve diesel imports reduce risk of future oil spills 2259 1First wind turbines on Galapagos Islands will halve diesel imports reduce risk of future oil spills 2259 2First wind turbines on Galapagos Islands will halve diesel imports reduce risk of future oil spills 2259 3First wind turbines on Galapagos Islands will halve diesel imports reduce risk of future oil spills 2259 45W Public Relations Hosts Exclusive Beauty 26 Wellness Industry Event 12165 15W Public Relations Hosts Exclusive Beauty 26 Wellness Industry Event 12165 2Is transgenic cotton more profitable 3F 2258 1Is transgenic cotton more profitable 3F 2258 2Congressman Buchanan Tours Florida Clinical Laboratory 3B Learns Vital Role in Patient Care 12159 1Congressman Buchanan Tours Florida Clinical Laboratory 3B Learns Vital Role in Patient Care 12159 2...LBERG, Germany, 11 July 2007 – On 23 July SY...nical phase IIa study for,AX200 (AXIS-study)., AX2... most,advanced drug candidate in SYGNIS’ pro...show safety and tolerability of,AX200 in acute str...pected to provide information for the further clin...
...TLE, July 11, 2007 /PRNewswire-FirstCall/ -- On We...p.m. Eastern/10:30 p.m.,Central European Time memb...team will host a conference call to discuss today,... II/III RAPID trial,comparing CHOP-R to CPOP-R, in...n standard CHOP-R, in first-line treatment of pati...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: